B cells as a therapeutic target in autoimmune disease
Depleting B cells with anti-CD20 monoclonal antibodies emerges as a new therapeutic strategy in autoimmune diseases. Preliminary clinical studies suggest therapeutic benefits in patients with classic autoantibody-mediated syndromes, such as autoimmune cytopenias. Treatment responses in rheumatoid ar...
Main Authors: | Goronzy, Jörg J, Weyand, Cornelia M |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2003
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165047/ |
Similar Items
-
Ageing, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity – catalysts of autoimmunity and chronic inflammation
by: Goronzy, Jörg J, et al.
Published: (2003) -
T-cell metabolism in autoimmune disease
by: Yang, Zhen, et al.
Published: (2015) -
The Janus Head of T Cell Aging – Autoimmunity and Immunodeficiency
by: Goronzy, Jörg J., et al.
Published: (2013) -
Association of MHC and rheumatoid arthritis:HLA polymorphisms in phenotypic variants of rheumatoid arthritis
by: Weyand, Cornelia M, et al.
Published: (2000) -
Cell-cell interactions in synovitis: Interactions between T cells and B cells in rheumatoid arthritis
by: Weyand, Cornelia M, et al.
Published: (2000)